Resources Contact Us Home
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety

Image Number 13 for United States Patent #8119616.

The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

  Recently Added Patents
Highly stable electrolytic water with reduced NMR half line width
Volume compensation within a photovoltaic device
Technique for skipping irrelevant portions of documents during streaming XPath evaluation
Semiconductor device and manufacturing method thereof
Qualification screening system and screening method thereof, qualification screening device and device under qualification screening
Device for installing conducting components in structures
Information display device and program storing medium
  Randomly Featured Patents
Liquid soap dispenser
Recovering data from arrays of storage devices after certain failures
Pyrimidone derivatives as bronchodilators
Process for producing biocompatible polyisoprene-polyurethane interpenetrating polymer network compositions for use in medical devices and the like
Compact spotting scope with side focus control
Virtual network using asynchronous transfer mode
Oxidation catalyst unit and a wet-type electrophotographic image forming apparatus comprising the same and a method thereof
Method for high-dimensionality indexing in a multi-media database
Lifting-table-guide arrangement